Cellulitis Epidemiology Forecast 2025-2034

In the United States, approximately 14 million cellulitis cases are reported annually. Depending on the location of the infection, cellulitis is classified into different types, including facial cellulitis, periorbital cellulitis, perianal cellulitis, and breast cellulitis. The cellulitis epidemiology forecast suggests that the prevalence of cellulitis is influenced by age, comorbidities (like diabetes and obesity), and compromised immunity. Moreover, chronic conditions like lymphedema and skin injuries are reported to further increase susceptibility to cellulitis.

Cellulitis Epidemiology Forecast Report Coverage

The “Cellulitis Epidemiology Forecast Report 2025-2034” offers comprehensive information on the prevalence and demographics of cellulitis. It projects the future incidence and prevalence rates of cellulitis cases across various populations. The study covers age, gender, and type as major determinants of the cellulitis population. The report highlights patterns in the prevalence of cellulitis over time and projects future trends based on multiple variables.

The report provides a comprehensive overview of the disease, as well as historical and projected data on the cellulitis epidemiology in the 8 major markets.

Regions Covered

• The United States
• Germany
• France
• Italy
• Spain
• The United Kingdom
• Japan
• India

Cellulitis Understanding: Disease Overview

Cellulitis refers to a bacterial infection caused by Group A Streptococcus (a common type of strep) and Staphylococcus aureus (staph infection) occurring in the middle and deep layers of the skin. The infection commonly affects the lower legs and feet and is prevalent among older adults. Individuals with a chronic health issue, such as vascular disease or diabetes, and immunocompromised people have a higher risk of developing cellulitis. Common symptoms include redness, swelling, warmth, and pain in the affected area, often on the legs, though it can occur anywhere on the body. In more severe cases, patients may experience fever, chills, fatigue, and swollen lymph nodes.

Cellulitis Epidemiology Perspective

The cellulitis epidemiology division offers information on the patient pool from history to the present as well as the projected trend for each of the 8 major markets. The publisher provides both current and predicted trends for the cellulitis epidemiology scenario by examining a wide range of studies. Additionally, the report covers the diagnosed patient pool for cellulitis and their trends. The cellulitis detailed epidemiology segmentation is broken down into specific categories, such as total prevalent cases in males and females, and total diagnosed cases across different age groups and patient pools.

• A population-based study revealed that there are about 50 cellulitis cases per 1000 patient-years, with the condition frequently occurring in middle-aged and older adults.
• Around 3% of emergency medical consultations were attributed to cellulitis at one United Kingdom district general hospital.
• Cellulitis is reported to affect both men and women equally. It is more prevalent among adults who are 50 years and above .
• Serious cellulitis cases require hospitalization to manage the condition, with nearly 650,000 people hospitalized for cellulitis treatment annually.

Age-Based Cellulitis Epidemiology Insights

A 2022 prospective, observational clinical study of 100 cellulitis patients, consisting of 57 males and 43 females, found the average age of cellulitis incidence to be 54.61 years, with ages ranging from 21 to 90. The incidence was estimated to be higher in males (57%) compared to females (43%). Most patients (94%) had cellulitis in one limb, while only 6% had bilateral involvement.

Gender-Based Cellulitis Epidemiology Insights

A retrospective analysis using data from the Spanish Health Ministry of 194,673 cellulitis hospitalizations (2016-2022) found women had a lower overall hospitalization rate than men, but higher rates in those aged = 80 years. Risk factors for cellulitis in women included age, hypertension, obesity, heart failure, and infections by E. coli. Major mortality risks for both genders included age = 80, leukemia, heart failure, and neurodegenerative diseases.

Country-wise Cellulitis Epidemiology Segment

The cellulitis epidemiology data and findings from the United States, Germany, Spain, Italy, France, the United Kingdom, Japan, and India are also provided in the epidemiology section.

The epidemiology of cellulitis varies between countries owing to differences in the prevalence of underlying health conditions and risk factors (such as diabetes, skin injuries, or immunocompromised states), healthcare access, population demographics, sanitation, and climate. In the United States, an estimated 14 million cellulitis cases are reported each year.

Cellulitis: Treatment Overview

Antibiotics are typically used for cellulitis treatment. For mild cellulitis, oral antibiotics are prescribed for a duration of 5 to 10 days. However, intravenous (IV) antibiotics are required for severe cellulitis. If an abscess is present, incision and drainage may be necessary, and antibiotic therapy is adjusted based on culture and sensitivity results. In addition to cellulitis therapeutics, proper wound care and addressing underlying risk factors (such as diabetes, lymphedema, or skin conditions) are also needed to prevent recurrence.

Healthcare providers also recommend that the patient rest until improvement of symptoms is observed. Patients are advised to seek immediate hospitalization if conditions like low blood pressure, a very high temperature, nausea, or vomiting do not go away.

Key Questions Answered

• What are the key findings of cellulitis epidemiology in the 8 major markets?
• What will be the total number of patients with cellulitis across the 8 major markets during the forecast period?
• What was the country-wise cellulitis epidemiology scenario in the 8 major markets in the historical period?
• Which country will have the highest number of cellulitis patients during the forecast period of 2025-2034?
• Which key factors would influence the shift in the patient population of cellulitis during the forecast period of 2025-2034?
• What are the currently available treatments in the cellulitis market?
• What are the disease risks, signs, symptoms, and unmet needs of cellulitis?

Scope of the Cellulitis Epidemiology Report

• The report covers a detailed analysis of signs and symptoms, causes, risk factors, pathophysiology, diagnosis, treatment options, and classification/types of cellulitis based on several factors.
• Cellulitis Epidemiology Forecast Report covers data for the eight major markets (the US, France, Germany, Italy, Spain, the UK, Japan, and India).
• The cellulitis report helps to identify the patient population and the unmet needs are highlighted along with an assessment of the disease's risk and burden.

This product will be delivered within 3-5 business days.